	Fatigue
Armodafinil
Obstructive sleep apnea syndrome
Sleepiness
Wakefulness
	nCPAP use
episodic secondary memory
patients
visit
final visit
armodafinil
sleepiness
analysis
residual ES
past 24 h
day
baseline
fatigue
effects
placebo
nCPAP-adherent patients
studies
therapy
long-term memory
adverse events
cognitive function
score greater
tests
placebo groups
week
daily living
clinical condition
nCPAP
clinically significant elevations
OSA studies
Clinical Global Impression
equal
Cognitive impairment
action
wakefulness
adjunctive treatment
Wakefulness Test
significant amounts
daily
present
scores
treatment
greater
hypertension

